You are here
Open
NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.
If no search results for your keyword(s) were found, you are encouraged to review Agency omnibus solicitations for additional funding opportunities. Omnibus solicitations are structured to be broad, extensive Programmatic issuances with research areas related to the petitioning Agency and are not limited to predetermined Topics/Subtopics. If upon reviewing you have additional questions, you may consider reaching out to the respective Agency for clarification regarding acceptable proposals (https://www.sbir.gov/agency-contacts).
-
PAR-22-102: Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
Release Date: 01-21-2022Open Date: 02-28-2022 Due Dates: Multiple Close Date: 12-05-2024Background Currently, there are only three medications (four formulations) approved by the FDA for the treatment of alcohol use disorder (AUD). The need for additional medications to treat those affected by AUD is urgently needed.In addition,alcohol misuseaffects virtually all tissues and is linked with dysfunction and failure of many organs and systems including the liver, heart, pancreas, lung, ...
STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
PAR-22-103: Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)
Release Date: 01-21-2022Open Date: 02-28-2022 Due Dates: Multiple Close Date: 12-05-2024Background Currently, there are only three medications (four formulations) approved by the FDA for the treatment of alcohol use disorder (AUD). The need for additional medications to treat those affected by AUD is urgently needed.In addition,alcohol misuseaffects virtually all tissues and is linked with dysfunction and failure of many organs and systems including the liver, heart, pancreas, lung, ...
STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
SF24A-T004: Integrated lasers and non-magnetic isolators for optical clock technologies
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Quantum Science; Advanced Materials The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120-130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Export Administration Regulation (EAR), 15 CFR Parts 730-774 ...
STTRPhase IDepartment of DefenseAir Force -
AF241-D021: In-Place Heat Treat for Incrementally Formed Parts
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Advanced Materials OBJECTIVE: Research, evaluate, and ultimately deploy the ability to heat treat incrementally formed sheet metal parts directly on the forming equipment without removing the part. DESCRIPTION: Metal is typically formed in a soft state. After forming, the part is typically heat treated to make it harder and applicable for use on an a ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
PAR-23-267: Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Release Date: 04-18-2023Open Date: 05-06-2023 Due Dates: Multiple Close Date: 06-07-2025Purpose This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I and Phase II (Fast track and Direct to phase II) grant applications. The funding opportunity will utilize a U43/U44 cooperative agreement to support SBCs to propose the development of novel extracellular vesicle-based therape ...
SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
PAR-23-268: Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Release Date: 04-18-2023Open Date: 05-06-2023 Due Dates: Multiple Close Date: 06-07-2025Purpose This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) Phase I and Phase II (Fast track) grant applications. The funding opportunity will utilize a UT1/UT2 cooperative agreement to support SBCs to propose the development of novel extracellular vesicle (EV)-based therapeutic platforms for ...
STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health -
AF241-0010: Improved Digital Engineering Techniques for Test Data Leveraging
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Advanced Computing and Software OBJECTIVE: Develop and demonstrate a data analysis tool methodology to capture relevant test parameters from past data into a usable form and create a digital engineering-level model capable of evaluating variables and providing accurate predictive answers. Models must be able to quickly learn from new data to improve pre ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
SF24A-T005: High Throughput Visible-Wavelength Multispectral Filter Arrays via Spectral Multiplexing
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Space Technology The technology within this topic is restricted under the International Traffic in Arms Regulation (ITAR), 22 CFR Parts 120-130, which controls the export and import of defense-related material and services, including export of sensitive technical data, or the Export Administration Regulation (EAR), 15 CFR Parts 730-774, which controls du ...
STTRPhase IDepartment of DefenseAir Force -
AF241-0012: High Temperature Mach number or Static Pressure Probes for Vitiated Flows
Release Date: 11-29-2023Open Date: 01-03-2024Due Date: 02-07-2024Close Date: 02-07-2024OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Hypersonics; Integrated Sensing and Cyber; Advanced Materials OBJECTIVE: Develop and demonstrate a local Mach number or Static Pressure probe technology suitable for hypersonic and high enthalpy flows. DESCRIPTION: The Aerodynamic and Propulsion Test Unit (APTU) at the Arnold Engineering Development Complex (AEDC) is a high-speed hypersonic (HS/H) te ...
SBIRPhase I/Phase IIDepartment of DefenseAir Force -
RFA-NS-23-007: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Release Date: 09-15-2022Open Date: 12-04-2022 Due Dates: Multiple Close Date: 04-05-2025Purpose The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. Specifically, this FOA is focused on applications directed at improving pain measurement ...
STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health